Search
ACTINOGEN LIMITED (ACW)

ACTINOGEN LIMITED (ACW)

  Print

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Actinogen Limited
Stock Code: ACW
Website: www.actinogen.com.au
GICS Sub-Industry: Biotechnology
Market Cap ($M): 1
Equiv. Shares (M): 58

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.026 $ 0.026 $ 0.026 $ 0.026 $ 0.024 30,000 $ 0.002  8.333 %

Company Overview

Business Description:
Actinogen Limited (ACW) is a biotechnology company engaged in the commercialisation of bioactive compounds. ACW focuses on the detection and isolation of soil actinomycetes found in Western Australia and the semi-purification and screening of bioactive compounds produced by actinomycetes. ACW focuses on the Antibiotic & Antifungals Project from Soil and Water Isolates.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2011  A -0.7 -1.7 -- 0.0 0.0 0.0 --
2010  A -0.7 -1.6 -- 0.0 0.0 0.0 --
2009  A -0.9 -2.0 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2009 A 2010 F 2011 F 2009 A 2010 F 2011 F 2009 A 2010 F 2011 F
Actinogen (ACW) $1 M -- -- -- -- -- -- 0.0000 -- --
CSL (CSL) $19,341 M 0.0602 0.0718 0.1564 21.7742 20.3160 17.5683 0.0212 0.0226 0.0247
Mesoblast (MSB) $1,895 M -- -- -- -- 512.3077 -- 0.0000 0.0000 0.0000
Phosphagenics (POH) $179 M -- -- -- 134.6154 -- -- 0.0000 0.0000 0.0000
Starpharma (SPL) $439 M -- -- -- -- -- -- 0.0000 0.0000 0.0000

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
ACW -- -- 1.23 -- 20.0
Market 1.12 11.1 0.96 2.31 2.55
Sector 0.95 22.0 2.13 7.54 10.31

Directors
Name Position Start Date
Dr Zhukov (Zeke) Pervan Executive Chairman,Executive Director 12 October 2007
Mr David Alan Zohar Executive Director 12 October 2007
Dr David Keast Executive Director,Scientific Director 01 November 2003
Professor Alan R Morton Non-Executive Director 18 July 2007
Mr Simon Christopher England Non-Executive Director 18 July 2007

Management
Name Position
Suraj Sanghani Company Secretary

Substantial Shareholders
Holding Name
7,133,334 (17.89%) Dr Zhukov Pervan
3,733,333 (9.36%) Associate Prof David Keast

Calendar of Events
Date Event
27 February 2013 Report (Interim)
04 October 2012 Report (Annual)
30 August 2012 Report (Annual)
28 August 2012 Report (Prelim)
Search for Managed Funds, Superannuation Funds and Retirement Funds Find a Managed Fund Reduce your fees and save money on your Managed Funds with our 100% Entry Fee Rebate 100% Entry Fee Rebate

Login
Email
Password
     Log me in automatically in future
Forgotten password? | Secure Login | Terms & Conditions
Free Membership

Membership benefits...

  • 100% entry fee rebates
  • Cash back on your managed fund investments with our innovative TrailCap™ program
  • Independent research on...
    • over 1,000 managed funds
    • over 300 ASX-listed Companies
    • top performing suburbs/postcodes
  • Access to IPOs/floats & other investment offers
  • Superior investment tools...
    • Portfolio manager
    • Watchlists
    • Alerts
  • Regular investment e-newsletter

Advertisement

Portfolio / Watchlist

Start a new portfolio / view your existing portfolio.
Track all your assets and manage your investments easily.

Trade Shares Online from $19.95^

eNewsletter

Keep up to date with new investments and important news - subscribe to our FREE weekly eNewsletters. Sign up now!

Free Guides

The Essential Guide to Investment Fees

An educational booklet to help you find out everything you must know about investment fees.

More details...


News

Hindsight is a wonderful thing - and so is the market

Sydney Morning Herald 26/05/2012 | A huge buying opportunity. It has gone up ever since.

Come hither and run barefoot among my stocks of memories

The Age 26/05/2012 | I WAS reading some old Marcus Today newsletters. From 2003. Let me take you back and allow you to exercise the power of hindsight:

Briefs

Sydney Morning Herald 26/05/2012 | CONSTRUCTION

IN BRIEF

The Age 26/05/2012 | IRON ORE

IN BRIEF

The Age 25/05/2012 | RADIO People are six times more likely to go to an advertiser's website if they have heard the ad on radio, according to research by Colmar Brunton, released by Commercial Radio Australia. The research showed that radio advertising has an immediate effect on people's digital activity, with more than three-quarters of those exposed to advertising visiting a website or Facebook page or searching for the brand online within 24 hours. Commercial Radio Australia chief executive Joan Warner said the ...

Find a beta stock in rebound or rue one that got away

Sydney Morning Herald 24/05/2012 | The brutal selloff in shares between May 1 and May 18 has been very instructive for traders.

More...


Sponsored Links

More from our network...